Shanshan Xu

CEO & Founder at Bambusa Therapeutics

Speaker

Shanshan Xu, MD, PhD, is the Founder and Chief Executive Officer of Bambusa Therapeutics, a rapidly growing clinical-stage biotechnology company specializing in developing transformative inflammatory and immunological (I&I) therapeutics. Bambusa was founded with a belief that the I&I field is long overdue for innovative approaches and transformative cutting-edge solutions.

Prior to founding Bambusa, Shanshan served as the head of Global External Innovations at BioNTech, where she and her team identified best-in-class assets and technologies to transform BNT’s pipeline. Her team’s accomplishments include the partnership of Duality and OncoC4 - both Tier 1 oncology programs. Before receiving the call to join BioNTech in 2020, Shanshan also spent time on Wall Street as a Research Analyst.

Originally from Harbin, China, Shanshan spent almost half of her life in Mainland China, where she received her medical degree. She also holds a Ph.D. from UC-Irvine and an MBA from MIT.